A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2002
12/19/2002	WO2002100827A2 Method for increasing the survival of dopamine secreting cells
12/19/2002	WO2002100826A2 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
12/19/2002	WO2002100825A2 Anthranilic acid amides with a heteroarylsulfonyl side chain, and use thereof as antiarrhythmic active substances
12/19/2002	WO2002100824A1 A novel alkaloid derivative and a pharmaceutical composition containing the same
12/19/2002	WO2002100823A1 New compounds useful in reflux disease
12/19/2002	WO2002100822A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
12/19/2002	WO2002100820A1 Substituted aminoalcohols useful in treatment of alzheimer's disease
12/19/2002	WO2002100819A1 N-arylphenylacetamide derivatives and medicinal compositions containing the same
12/19/2002	WO2002100818A2 Aminediols as agents for the treatment of alzheimer's disease
12/19/2002	WO2002100813A2 Modulators of peroxisome proliferator activated receptors
12/19/2002	WO2002100811A1 S-methylcysteine s-ethylcysteine and related s-alkylthiols as antagonists to the effects of s-nitrosothiols and nitric oxide
12/19/2002	WO2002100456A1 Using supercritical fluids to infuse therapeutic on a medical device
12/19/2002	WO2002100453A1 Crosslinkable macromers
12/19/2002	WO2002100439A1 Water-soluble stabilized self-assembled polyelectrolytes
12/19/2002	WO2002100437A2 Ophthalmic compositions comprising hyaluronic acid
12/19/2002	WO2002100434A1 Treatment of neuropathic pain with n-methyl-d-aspartate (nmda) receptor antagonists
12/19/2002	WO2002100433A1 Medicinal compositions
12/19/2002	WO2002100431A1 A pharmaceutical kit comprising anti-human seminal plasma protein single chain antibody/human carboxypeptidase fusion protein and prodrug
12/19/2002	WO2002100429A1 Combination therapies using vitamin b12 and interferon for treatment of viral, proliferative and inflammatory diseases
12/19/2002	WO2002100428A1 Combination therapies using vitamin b12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases
12/19/2002	WO2002100422A1 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating
12/19/2002	WO2002100421A1 Low molecular weight components of cartilage, complexes of copper with amino acids or di-peptides; processes for preparation and therapeutic uses thereof
12/19/2002	WO2002100420A2 Pharmaceutical zeolite-based compositions containing zinc and erythromycin, to be used in the treatment of acne
12/19/2002	WO2002100417A2 Use of glycosaminoglycans for the treatment of hiv-associated nephropathy
12/19/2002	WO2002100415A2 4'-substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus
12/19/2002	WO2002100414A1 Arylazo-substituted imidazole for the treatment of stress urinary incontinence
12/19/2002	WO2002100413A1 A PHARMACEUTICAL COMBINATION COMPRISING EITHER (S)-2-ETHOXY-3- [4-(2-{4-METHANE SULFONYL OXYPHENYL} ETHOXY) PHENYL] PROPANOIC ACID OR 3-{4-[2-(4-TERT- BUTOXY CARBONYL AMINOPHENYL) ETHOXY] PHENYL} -(s)-2-ETHOXY PROPANOIC ACID AND A SULONYLUREA
12/19/2002	WO2002100412A2 Stabilized dispersion of phytosterol in oil
12/19/2002	WO2002100411A1 Naphtothiazine positive allosteric ampa receptor modulators (paarm)
12/19/2002	WO2002100410A1 Methods of treating alzheimer's disease
12/19/2002	WO2002100409A1 Antiinflammatoric and antitussive compositions
12/19/2002	WO2002100408A2 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels
12/19/2002	WO2002100407A1 Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same
12/19/2002	WO2002100406A1 Use of yohimbine in the preparation of immunobiologically active drugs
12/19/2002	WO2002100405A1 Isoquinoline inhibitors of p38
12/19/2002	WO2002100404A2 Pyridoxal in combination with serotonin re-uptake inhibitor for the treatment of hot flushes
12/19/2002	WO2002100403A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/19/2002	WO2002100402A1 Compositions comprising nitrofurantoin and uva ursi
12/19/2002	WO2002100400A1 Organic nitrate-based compounds for the treatment of vasculopathies
12/19/2002	WO2002100399A1 Macrocycles useful in the treatment of alzheimer's disease
12/19/2002	WO2002100398A1 Combination of a ptpase inhibitor and an ace inhibitor
12/19/2002	WO2002100397A1 COMBINATION OF A PTPase INHIBITOR AND AN ANTILIPEMIC AGENT
12/19/2002	WO2002100396A1 COMBINATION OF A PTPase INHIBITOR AND A THIAZOLIDINEDIONE AGENT
12/19/2002	WO2002100395A1 Bismuth salts of anti-oxidants and radical scavengers for prevention and treatment of mucous membrane ulcers
12/19/2002	WO2002100394A1 Oral pharmaceutical composition containing a statin derivative
12/19/2002	WO2002100393A1 Compositions for ameliorating attention-deficient/hyperactivity disorder
12/19/2002	WO2002100392A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
12/19/2002	WO2002100391A1 Swallow tablet comprising paracetamol
12/19/2002	WO2002100390A2 Improved method of treating the syndrome of coronary heart disease risk factors in humans
12/19/2002	WO2002100389A2 Compressible guaifenesin compositions and method for producing them
12/19/2002	WO2002100388A2 Cyclopentane heptan (ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension
12/19/2002	WO2002100387A1 Prevention of neovascularization of intervertebral discs and/or of tissues with local inflammation
12/19/2002	WO2002100386A1 Controlled heat induced rapid delivery of pharmaceuticals from skin depot
12/19/2002	WO2002100382A2 Controlled release dosage forms using acrylic polymer, and process for making the same
12/19/2002	WO2002100377A1 PHARMACEUTICAL FORMULATION FOR THE EFFICIENT ADMINISTRATION OF APOMORPHINE, 6aR-(-)-N-PROPYL-NORAPOMORPHINE AND THEIR DERIVATIVES AND PRO-DRUGS THEREOF
12/19/2002	WO2002100376A1 Ophthalmic compositions comprising chitosan and an active substance, in particular ketotifen, and use thereof for the treatment of ocular allergic conditions
12/19/2002	WO2002100373A1 Skin preparation
12/19/2002	WO2002100370A1 Breath protection microcapsules
12/19/2002	WO2002100361A1 Shaving preparations and methods for the prevention and treatment of pseudofolliculitis barbae
12/19/2002	WO2002100359A1 Preparation for hair and/or scalp
12/19/2002	WO2002100354A2 Pyrrolo[2,3-d]pyrimidine nucleoside analogs
12/19/2002	WO2002100353A2 Cd10-activated prodrug compounds
12/19/2002	WO2002100352A2 Nr2b receptor antagonists for the treatment or prevention of migraines
12/19/2002	WO2002100351A2 A method for treating inflammatory diseases by administering a ppar-delta agonist
12/19/2002	WO2002100350A2 Dopamine receptor ligands and therapeutic methods based thereon
12/19/2002	WO2002100349A2 Use of the parathroid hormone-2 (pth2) receptor to screen for agents to treat pain
12/19/2002	WO2002100348A2 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
12/19/2002	WO2002100347A2 Prodrugs of gaba analogs, compositions and uses thereof
12/19/2002	WO2002100346A2 (r, r'),(r',s')-amphetaminil, compositions and uses thereof
12/19/2002	WO2002100344A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
12/19/2002	WO2002100342A2 (s, s'), (s, r')-amphetaminil, compositions and uses thereof
12/19/2002	WO2002100341A2 Compounds for the treatment of metabolic disorders
12/19/2002	WO2002100336A2 Tissue-specific endothelial membrane proteins
12/19/2002	WO2002100332A2 Isoxazoline compounds having mif antagonist activity
12/19/2002	WO2002100330A2 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES
12/19/2002	WO2002100329A2 Methods and compositions for helping the body resist the effects of the aging process
12/19/2002	WO2002100328A2 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
12/19/2002	WO2002100327A2 Substituted 1-benzazepines and derivatives thereof
12/19/2002	WO2002100323A2 METHYL ANALOGS OF SIMVASTATIN AS NOVEL HMG-CoA REDUCTASE INHIBITORS
12/19/2002	WO2002100319A2 Method for cleaning hard gelatine capsules
12/19/2002	WO2002100309A1 Quinolone carboxylic acid compositions and related methods of treatment
12/19/2002	WO2002100295A2 Facially amphiphilic polymers as anti-infective agents
12/19/2002	WO2002100250A2 Wit 3.0, a novel gene to control soft tissue wound healing
12/19/2002	WO2002100248A2 Compositions and methods relating to glucose metabolism, weight control, and food intake
12/19/2002	WO2002100193A1 Body temperature-raising agent of amino acids for eating or drinking and for medical use
12/19/2002	WO2002100189A1 Health feed
12/19/2002	WO2002100148A2 Treatment or prophylaxis of insulin-producing cell graft rejection
12/19/2002	WO2002092606A8 Fused imidazolidine derivatives, process for preparation of the same and use thereof
12/19/2002	WO2002088144A3 ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO[2,3-f]QUINOXALINE
12/19/2002	WO2002087604A3 Preparations containing a combination of vitamin e and afamin
12/19/2002	WO2002087583A3 Use of hiv-protease inhibitors to block cell migration and/or invasion, tissue infiltration and oedema formation
12/19/2002	WO2002085906A3 Phthalazinones derivatives useful as pde4/7 inhibitors
12/19/2002	WO2002085853A3 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
12/19/2002	WO2002085358A3 Antiviral agents and methods of treating viral infections
12/19/2002	WO2002085327A3 Use of nsaids for prevention and treatment of cellular abnormalities of the female reproductive tract
12/19/2002	WO2002085308A3 Antisense and anti-inflammatory based compositions to treat respiratory disorders
12/19/2002	WO2002083651A3 Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents
12/19/2002	WO2002082904A3 Method of treating or retarding the development of blindness
12/19/2002	WO2002082075A9 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
12/19/2002	WO2002081677A3 Improved gene expression

1 ... 5613 5614 5615 5616 5617 5618 5619 5620 5621 5622 5623 5624 5625 5626 5627 5628 5629 5630 5631 5632 5633 ... 7860